Q32 Bio (QTTB) Capital Expenditures Growth (1y) (2018 - 2026)
Q32 Bio (QTTB) Capital Expenditures Growth (1y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Capex Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
- |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
- |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
227.76% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Q32 Bio |
167.59 Mn |
116.84 Mn |
- |
-29.15% |
| Date | Value |
|---|
| Mar 31, 2026 |
-29.15% |
| Dec 31, 2025 |
282.35% |
| Jun 30, 2025 |
-210.76% |
| Mar 31, 2025 |
114.78% |
| Sep 30, 2024 |
238.22% |
| Jun 30, 2024 |
16.75% |
| Mar 31, 2024 |
2,200.00% |
| Sep 30, 2023 |
-3,283.33% |
| Jun 30, 2023 |
-84.23% |
| Mar 31, 2023 |
-91.53% |
| Dec 31, 2022 |
-95.65% |
| Sep 30, 2022 |
110.00% |
| Jun 30, 2022 |
267.50% |
| Mar 31, 2022 |
-92.78% |
| Dec 31, 2021 |
107.76% |
| Sep 30, 2021 |
-138.22% |
| Jun 30, 2021 |
-132.63% |
| Mar 31, 2021 |
101.73% |
| Dec 31, 2020 |
-1,075.33% |
| Sep 30, 2020 |
101.00% |
